188 related articles for article (PubMed ID: 38188680)
1. Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cells.
Ghorbani R; Gharbavi M; Sharafi A; Rismani E; Rezaeejam H; Mortazavi Y; Johari B
Oncol Res; 2023; 32(1):101-125. PubMed ID: 38188680
[TBL] [Abstract][Full Text] [Related]
2. Combinational therapy with Myc decoy oligodeoxynucleotides encapsulated in nanocarrier and X-irradiation on breast cancer cells.
Johari B; Parvinzad Leilan M; Gharbavi M; Mortazavi Y; Sharafi A; Rezaeejam H
Oncol Res; 2023; 32(2):309-323. PubMed ID: 38186581
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line.
Faghfoori MH; Nosrati H; Rezaeejam H; Charmi J; Kaboli S; Johari B; Danafar H
Int J Pharm; 2020 May; 582():119320. PubMed ID: 32278720
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line.
Johari B; Rahmati M; Nasehi L; Mortazavi Y; Faghfoori MH; Rezaeejam H
Cell Biol Int; 2020 Dec; 44(12):2499-2511. PubMed ID: 32841450
[TBL] [Abstract][Full Text] [Related]
6. Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model.
Leung S; Miyake H; Zellweger T; Tolcher A; Gleave ME
Int J Cancer; 2001 Mar; 91(6):846-50. PubMed ID: 11275990
[TBL] [Abstract][Full Text] [Related]
7. Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.
Pan M; Li W; Yang J; Li Z; Zhao J; Xiao Y; Xing Y; Zhang X; Ju W
Medicine (Baltimore); 2017 Jul; 96(30):e7405. PubMed ID: 28746182
[TBL] [Abstract][Full Text] [Related]
8. NANOG Decoy Oligodeoxynucleotide-Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme Cells.
Gharbavi M; Johari B; Rismani E; Mousazadeh N; Taromchi AH; Sharafi A
ACS Chem Neurosci; 2020 Dec; 11(24):4499-4515. PubMed ID: 33283497
[TBL] [Abstract][Full Text] [Related]
9. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
[TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative, apoptotic potential of synthesized selenium nanoparticles against breast cancer cell line (MCF7).
Soltani L; Darbemamieh M
Nucleosides Nucleotides Nucleic Acids; 2021; 40(9):926-941. PubMed ID: 34396908
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
Wang T; Li QH; Hao GP; Zhai J
Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
[TBL] [Abstract][Full Text] [Related]
12. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
Gleave M; Tolcher A; Miyake H; Nelson C; Brown B; Beraldi E; Goldie J
Clin Cancer Res; 1999 Oct; 5(10):2891-8. PubMed ID: 10537358
[TBL] [Abstract][Full Text] [Related]
13. Genistein-selenium combination induces growth arrest in prostate cancer cells.
Kumi-Diaka J; Merchant K; Haces A; Hormann V; Johnson M
J Med Food; 2010 Aug; 13(4):842-50. PubMed ID: 20553187
[TBL] [Abstract][Full Text] [Related]
14. Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone.
Sun G; Sun K; Sun J
Drug Deliv; 2021 Dec; 28(1):1132-1140. PubMed ID: 34121558
[TBL] [Abstract][Full Text] [Related]
15. PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic.
Huang B; Otis J; Joice M; Kotlyar A; Thomas TP
Biomacromolecules; 2014 Mar; 15(3):915-23. PubMed ID: 24392665
[TBL] [Abstract][Full Text] [Related]
16. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B
Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of Methotrexate Loaded Chitosan Nanoparticles and in vitro Evaluation of the Potential in Treatment of Prostate Cancer.
Nur SG; Buket O; Sezgi K; Cagdas A; Cansu A; Guliz A; Habibe Y; Cigir BA; Yavuz D; Senay HS
Anticancer Agents Med Chem; 2016; 16(8):1038-1042. PubMed ID: 26721835
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: a novel therapy in prostate cancer.
Balaji KC; Koul H; Mitra S; Maramag C; Reddy P; Menon M; Malhotra RK; Laxmanan S
Urology; 1997 Dec; 50(6):1007-15. PubMed ID: 9426742
[TBL] [Abstract][Full Text] [Related]
19. Pomegranate Peel Extract Stabilized Selenium Nanoparticles Synthesis: Promising Antimicrobial Potential, Antioxidant Activity, Biocompatibility, and Hemocompatibility.
Hashem AH; Saied E; Ali OM; Selim S; Al Jaouni SK; Elkady FM; El-Sayyad GS
Appl Biochem Biotechnol; 2023 Oct; 195(10):5753-5776. PubMed ID: 36705842
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
